Search results
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
Investor's Business Daily· 1 year agoMerck is acquiring immunology-focused drugmaker Prometheus Bio in a well-timed $10.8 billion deal...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 5 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
In what could be a 'big shift' for cancer treatment, mRNA vaccine shows promise against melanoma
USA TODAY via Yahoo News· 1 year agoMessenger RNA vaccines aren't just for COVID anymore. The vaccine technology America learned about...
The Zacks Analyst Blog Highlights Merck, Equinor, Illinois Tool Works, Arthur J. Gallagher and...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – December 12, 2023 – Zacks.com announces the list of stocks...
Pharma Stock Roundup: SNY, MRK, NVS Report Q3 Earnings, FDA Okays PFE, LLY Products
Zacks via Yahoo Finance· 7 months agoThis week, Merck MRK, Sanofi SNY and Novartis NVS announced their third-quarter results. The FDA...
Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More
Zacks via Yahoo Finance· 6 months agoThis week, Pfizer PFE issued a disappointing guidance for 2024, which includes its expectations from...
Shingles Vaccine Market is Booming in Near Future 2023-2031
NewMediaWire via Yahoo Finance· 1 year agoPune, India - (NewMediaWire) - March 3, 2023 - "Shingles Vaccine" Size, Scope, and Forecast...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 2 weeks agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Canada faces shortage of measles vaccines amid rise in cases, demand
CBC via Yahoo News· 2 months agoCanada is facing a shortage of measles vaccines amid a rise in cases across the country and around...
Drug, Biotech Stocks' Q2 Earnings on Jul 28: MRK, PFE & More
Zacks via Yahoo Finance· 2 years agoThe earnings season for the pharma sector began last week when bigwig Johnson & Johnson reported...